Curetis and Heraeus Medical have partnered to develop a Unyvero cartridge, designed to detect pathogens and antibiotic resistance in implant and tissue infections. The test could be applied in orthopedics to diagnose infections after knee and hip replacement surgeries. The parties expect assay development for the new cartridge to be complete by early next year, with clinical validation and CE marking throughout 2013.
More Articles on Orthopedic Implants:
Houston Orthopedic and Spine Hospital Now Has Robotic Spine Surgery
32 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in August
Biomet Announces European Launch of Comprehensive Shoulder Device